American Thoracic Society International Conference
Healio Pulmonology brings you the highlights from the American Thoracic Society International Conference. Refer back to this page often for the latest news from ATS, perspectives, and interviews with leading researchers and clinicians, and to review archives of past meetings.
MEETING NEWS
Risk for exposure-related respiratory diseases varies among US military personnel
June 6, 2019
DALLAS — Risk for respiratory illnesses related to complex, poorly characterized inhalation exposures is a concern for U.S. military personnel…
IN THE JOURNALS
Decreased exposure to air pollutants in California reduced asthma incidence in children
June 3, 2019
Decreases in regional air pollutants were associated with reductions in asthma incidence among children in Southern California from 1993 to 2014…
MEETING NEWS
Four novel sepsis phenotypes identified
May 29, 2019
DALLAS — A new study has identified four clinical phenotypes of sepsis that may allow more precise therapy and improve care of critically ill…
MEETING NEWS
Combination therapy with treprostinil reduced risk for clinical worsening in PAH: FREEDOM EV
May 29, 2019
DALLAS — Adding treprostinil to monotherapy, as compared with placebo, reduced the risk for clinical worsening events in patients with…
MEETING NEWS
Two-year analysis demonstrates long-term safety, efficacy of benralizumab in severe asthma
May 28, 2019
DALLAS — In patients with severe asthma treated with benralizumab, reduced exacerbation rates and improved pulmonary function, asthma control…
MEETING NEWS
Novel smartphone app shows promise for smoking cessation
May 24, 2019
DALLAS — People using a novel smartphone application with an integrated mobile carbon monoxide checker were more likely to abstain from smoking…
MEETING NEWS
ASCENT-COPD: Aclidinium shows continued success in chronic obstructive pulmonary disease
May 23, 2019
DALLAS — Aclidinium reduces moderate to severe exacerbations without increasing cardiovascular event risk in patients with chronic obstructive…
MEETING NEWS
Investigational TORC1 inhibitor observed to reduce respiratory tract infections in elderly with asthma
May 22, 2019
DALLAS — In a phase 2b trial, an investigational TORC1 inhibitor was well tolerated and observed to reduce the incidence of respiratory tract…
MEETING NEWS
Bacterial pneumonia linked to chronic lung problems
May 22, 2019
Young children with bacterial pneumonia who were admitted to a pediatric ICU frequently had lung problems that lasted up to a year after discharge…
MEETING NEWS
Treprostinil dry powder safe, well tolerated in PAH
May 22, 2019
DALLAS — A dry powder formulation of treprostinil was safe and well tolerated at 2 months, with no drug-related serious adverse events, in…
MEETING NEWS
High-intensity dust exposure linked to airway abnormalities in World Trade Center firefighters
May 21, 2019
DALLAS — In firefighters who responded to the World Trade Center on 9/11, high-intensity dust exposure and early symptoms were associated with…
MEETING NEWS
E-cigarettes may weaken immune system’s response to flu
May 21, 2019
Research presented at the American Thoracic Society’s International Meeting suggests that although e-cigarettes and cigarettes can leave people…
MEETING NEWS
Eosinophil-guided therapy noninferior to standard treatment for COPD exacerbations
May 21, 2019
DALLAS — Patients with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalization who received eosinophil-guided…
MEETING NEWS
Early initiation of selexipag results in more pronounced treatment effect: GRIPHON
May 21, 2019
DALLAS — In a post hoc exploratory analysis of the GRIPHON study, treatment with selexipag, compared with placebo, improved clinical outcomes…
MEETING NEWS
Add-on benralizumab not linked to lower exacerbation rates in COPD
May 20, 2019
DALLAS — In patients with moderate to very severe chronic obstructive pulmonary disease who had a history of exacerbations, were on double or…
MEETING NEWSPERSPECTIVE
Nintedanib slows loss of pulmonary function in systemic sclerosis-associated interstitial lung disease
May 20, 2019
DALLAS — Patients with interstitial lung disease associated with systemic sclerosis treated with the tyrosine kinase inhibitor nintedanib…
MEETING NEWS
Early sedation with dexmedetomidine fails to lower mortality vs. usual care: SPICE III
May 20, 2019
DALLAS — Critically ill patients undergoing mechanical ventilation in the ICU who received early sedation with dexmedetomidine as the primary…
MEETING NEWS
Mild asthma may not require daily inhaled corticosteroids
May 19, 2019
DALLAS — In the SIENA trial, nearly three-quarters of patients with mild, persistent asthma had low sputum eosinophil levels and did not differ…
MEETING NEWS
ROSE: No mortality benefit with early neuromuscular blockade vs. usual care in ARDS
May 19, 2019
DALLAS — A strategy of early neuromuscular blockade with concomitant heavy sedation, compared with usual care, did not result in a significant…
MEETING NEWS
As-needed budesonide-formoterol bests albuterol for exacerbation prevention in mild asthma
May 19, 2019
DALLAS — Single combination inhaler treatment with budesonide-formoterol on an as-needed basis, compared with albuterol, more than halved the…
Source: